Comparing oral Gemifloxacin and intravenous Cefotaxime for treating spontaneous bacterial peritonitis
Comparative Study Between the Efficacy of Oral Gemifloxacin and Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
PHASE3 · Tanta University · NCT04168099
This study is testing whether taking Gemifloxacin by mouth works as well as getting Cefotaxime through an IV for treating people with spontaneous bacterial peritonitis.
Quick facts
| Phase | PHASE3 |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tanta University (other) |
| Locations | 1 site (Tanta) |
| Trial ID | NCT04168099 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of oral Gemifloxacin with intravenous Cefotaxime in treating patients diagnosed with spontaneous bacterial peritonitis. It aims to determine which treatment option provides better outcomes for patients suffering from this condition. The study is interventional and is conducted in a Phase 3 setting, indicating a focus on confirming efficacy and monitoring side effects in a larger patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with spontaneous bacterial peritonitis.
Not a fit: Patients with secondary peritonitis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective or convenient treatment option for patients with spontaneous bacterial peritonitis.
How similar studies have performed: Other studies have explored antibiotic treatments for spontaneous bacterial peritonitis, but the specific comparison of oral Gemifloxacin and intravenous Cefotaxime is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with spontaneous bacterial peritonitis Exclusion Criteria: * secondary peritonitis
Where this trial is running
Tanta
- Sherief Abd-Elsalam — Tanta, Egypt (RECRUITING)
Study contacts
- Principal investigator: Hala Shaaban El Gendy, Msc — Tanta University - Faculty of Medicine
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Spontaneous Bacterial Peritonitis